Medicare Enrolled
Dr. Joseph Gayagoy, M.D.
Internal Medicine · Lodi, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gayagoy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gayagoy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gayagoy
Dr. Joseph Gayagoy is an internal medicine specialist in Lodi, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gayagoy performed 2,968 Medicare services across 1,573 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gayagoy received a total of $29,680 from 86 pharmaceutical and/or device companies across 1835 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gayagoy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in CA
$29,680 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,968
Medicare services
Top 10% in CA for internal medicine
1,573
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~156 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
749 | $79 | $230 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
656 | $68 | $155 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
269 | $11 | $45 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
187 | $1 | $15 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
159 | $11 | $40 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
116 | $168 | $365 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
114 | $22 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
114 | $31 | $40 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
102 | $5 | $15 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
59 | $126 | $300 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
58 | $4 | $15 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
57 | $218 | $495 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
54 | $78 | $220 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
54 | $132 | $265 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
47 | $54 | $150 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
45 | $11 | $40 |
| Impacted earwax removal by physician Removal of impacted earwax from one or both ears by a physician on the same day as audiologic testing. |
31 | $39 | $115 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
29 | $49 | $140 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
21 | $73 | $155 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
19 | $160 | $350 |
| New patient office visit, complex (60-74 min) | 14 | $127 | $435 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
14 | $146 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$29,680
Total received (2018-2024)
Avg $4,240/year across 7 years
Top 4% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
1,835
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$29,503 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$177 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,389
2023
$3,227
2022
$4,333
2021
$4,682
2020
$4,045
2019
$4,752
2018
$5,253
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$338
ABBVIE INC.
$285
Novo Nordisk Inc
$270
Boehringer Ingelheim Pharmaceuticals, Inc.
$253
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$238
AstraZeneca Pharmaceuticals LP
$233
Corcept Therapeutics
$218
PFIZER INC.
$186
Merck Sharp & Dohme LLC
$172
GlaxoSmithKline, LLC.
$163
Amgen Inc.
$159
Astellas Pharma US Inc
$150
Bayer Healthcare Pharmaceuticals Inc.
$124
Otsuka America Pharmaceutical, Inc.
$108
Vanda Pharmaceuticals Inc.
$107
Lundbeck LLC
$86
Novartis Pharmaceuticals Corporation
$81
Janssen Pharmaceuticals, Inc
$55
Exact Sciences Corporation
$36
ViiV Healthcare Company
$33
Esperion Therapeutics, Inc.
$27
Axsome Therapeutics, Inc.
$19
Abbott Laboratories
$18
AIMMUNE THERAPEUTICS, INC.
$18
IRONWOOD PHARMACEUTICALS, INC
$13
Top 3 companies account for 26.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,179
Amgen Inc.
$2,883
Novo Nordisk Inc
$2,865
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,853
Lilly USA, LLC
$1,706
Janssen Pharmaceuticals, Inc
$1,564
PFIZER INC.
$1,177
ABBVIE INC.
$1,127
Kowa Pharmaceuticals America, Inc.
$1,064
Novartis Pharmaceuticals Corporation
$817
GlaxoSmithKline, LLC.
$703
AbbVie Inc.
$665
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$605
Corcept Therapeutics
$590
SANOFI-AVENTIS U.S. LLC
$541
Takeda Pharmaceuticals U.S.A., Inc.
$516
Esperion Therapeutics, Inc.
$500
Merck Sharp & Dohme LLC
$457
Merck Sharp & Dohme Corporation
$423
Astellas Pharma US Inc
$415
Otsuka America Pharmaceutical, Inc.
$398
AbbVie, Inc.
$330
Bayer HealthCare Pharmaceuticals Inc.
$301
Allergan Inc.
$291
Amarin Pharma Inc.
$290
Lundbeck LLC
$273
Allergan, Inc.
$272
E.R. Squibb & Sons, L.L.C.
$237
Bayer Healthcare Pharmaceuticals Inc.
$237
Forte Bio-Pharma LLC
$198
Biohaven Pharmaceutical Holding Company Ltd.
$197
Teva Pharmaceuticals USA, Inc.
$181
ACADIA Pharmaceuticals Inc
$164
Hikma Pharmaceuticals USA
$159
Coloplast Corp
$119
Regeneron Healthcare Solutions, Inc.
$112
ARBOR PHARMACEUTICALS, INC.
$110
Vanda Pharmaceuticals Inc.
$107
Eyevance Pharmaceuticals LLC
$98
Mylan Specialty L.P.
$94
Philips Electronics North America Corporation
$93
Endo Pharmaceuticals Inc.
$88
Biohaven Pharmaceuticals, Inc.
$87
DEXCOM, INC.
$83
Abbott Laboratories
$83
Radius Health, Inc.
$78
Boston Scientific Corporation
$73
Eisai Inc.
$73
IRONWOOD PHARMACEUTICALS, INC
$73
Sunovion Pharmaceuticals Inc.
$67
Dexcom, Inc.
$67
Axsome Therapeutics, Inc.
$63
Alfasigma USA, Inc.
$56
Xeris Pharmaceuticals, Inc.
$55
Ironwood Pharmaceuticals, Inc
$53
IDORSIA PHARMACEUTICALS US INC
$47
Genentech USA, Inc.
$47
Aytu BioScience, Inc
$43
AMAG Pharmaceuticals, Inc.
$40
Supernus Pharmaceuticals, Inc.
$37
Exact Sciences Corporation
$36
Amneal Pharmaceuticals LLC
$33
ViiV Healthcare Company
$33
Orexigen Therapeutics, Inc.
$30
Horizon Therapeutics plc
$30
Kyowa Kirin, Inc.
$28
Paratek Pharmaceuticals, Inc.
$27
IBSA Pharma Inc.
$24
Silk Road Medical, Inc.
$24
Sun Pharmaceutical Industries Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$20
Advanced Respiratory, Inc
$20
Neurocrine Biosciences, Inc.
$20
Resmed Corp
$20
Biogen, Inc.
$19
Almatica Pharma LLC
$19
KCI USA, Inc
$18
AIMMUNE THERAPEUTICS, INC.
$18
Preventice Services, LLC
$17
Actelion Pharmaceuticals US, Inc.
$16
Flexion Therapeutics, Inc.
$16
Seqirus USA Inc
$14
Acorda Therapeutics, Inc
$14
NESTLE HEALTHCARE NUTRITION INC.
$14
AKRIMAX PHARMACEUTICALS, LLC
$14
Nalpropion Pharmaceuticals LLC
$12
Top 3 companies account for 30.1% of all-time payments
Associated products mentioned in payments ›
(1635) US Standard Basic SV · (8874) inCourage · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APRETUDE · AREXVY · AUSTEDO · AVEED · Aimovig · AirFit · Amitiza · Androgel · Auvelity · BELSOMRA · BG Mini Plus · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · CHANTIX · COMIRNATY · CONTRAVE · COSENTYX · CREON · Cologuard Collection Kit · Creon · Crysvita · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · Dexilant · EDEX · ELIQUIS · EMGALITY · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · Enbrel · FANAPT · FARXIGA · FASENRA · FERAHEME · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · GARDASIL · GARDASIL 9 · GENERAL PAIN MANAGEMENT · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · INBRIJA · INGREZZA · INTRAROSA · INVOKANA · JANUVIA · JARDIANCE · KAPSPARGO · KRYSTEXXA · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · Levemir · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NALOCET · NAPRELAN · NEXLETOL · NUPLAZID · NURTEC ODT · NUZYRA · Nalocet · Natesto · OFEV · OPSUMIT · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RELISTOR · REXULTI · REYVOW · RYBELSUS · RYTARY · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SPINRAZA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUPERION · SYMBICORT · SYNTHROID · Saxenda · Stendra · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · The Vest System Model 105 Home Care · Tirosint · Titan · Tobradex ST · Tresiba · Trintellix · Tymlos · UBRELVY · Uloric · Utibron · VERQUVO · VIBERZI · VRAYLAR · Vascepa · Veozah · Victoza · WATCHMAN · Wegovy · Wellcentive Undiv · XARELTO · XIAFLEX · XIFAXAN · XIFIXAN · Xofluza · Xultophy 100/3.6 · Yupelri · ZENPEP · Zilretta · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
208
Per 100K population
26.4
County median income
$88,531
Nearest hospital
ADVENTIST HEALTH LODI MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gayagoy is a clinical cardiology specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gayagoy experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gayagoy performed 749 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gayagoy receive payments from pharmaceutical companies?
Yes. Dr. Gayagoy received a total of $29,680 from 86 companies across 1,835 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gayagoy's costs compare to other internal medicine physicians in Lodi?
Dr. Gayagoy's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gayagoy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Lodi
Browse internal medicine physicians in Lodi ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology